Link Between Malaria and Epstein-Barr Virus Reactivation
Author Information
Author(s): Chêne Arnaud, Donati Daria, Guerreiro-Cacais André Ortlieb, Levitsky Victor, Chen Qijun, Falk Kerstin I, Orem Jackson, Kironde Fred, Wahlgren Mats, Bejarano Maria Teresa
Primary Institution: Karolinska Institutet, Stockholm, Sweden
Hypothesis
Can the malaria protein CIDR1α induce reactivation of Epstein-Barr virus (EBV) in B cells?
Conclusion
CIDR1α from malaria can directly induce EBV reactivation in B cells, potentially increasing the risk of Burkitt lymphoma in children in malaria-endemic areas.
Supporting Evidence
- CIDR1α binds to EBV-positive B cells and increases their viral load.
- Stimulation with CIDR1α led to a significant increase in EBV genome copies.
- Children with Burkitt lymphoma showed increased EBV loads after CIDR1α stimulation.
Takeaway
A protein from malaria can wake up a virus that usually sleeps in our body, which might make kids more likely to get a certain type of cancer.
Methodology
The study used EBV-positive B cell lines and peripheral blood mononuclear cells to assess the effect of CIDR1α on EBV reactivation.
Potential Biases
Potential bias in the selection of cell lines and patient samples.
Limitations
The study primarily focused on in vitro experiments, which may not fully represent in vivo conditions.
Participant Demographics
Children with Burkitt lymphoma from Uganda, aged 4-7 years.
Statistical Information
P-Value
0.03
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website